ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
9 |
10:01 |
10:01 |
ASX - By Stock
|
212
|
82K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
10 |
06:33 |
06:33 |
ASX - By Stock
|
212
|
82K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
8 |
00:15 |
00:15 |
ASX - By Stock
|
212
|
82K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
8 |
00:04 |
00:04 |
ASX - By Stock
|
212
|
82K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
5 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
212
|
82K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
11 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
457
|
142K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
9 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
212
|
82K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
6 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
457
|
142K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
13 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
457
|
142K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
457
|
142K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
457
|
142K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
11 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
212
|
82K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
457
|
142K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
11 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
457
|
142K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
457
|
142K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
ddwn
|
18K |
10M |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
18K
|
10M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
457
|
142K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
8 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
457
|
142K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
ddwn
|
381 |
119K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
381
|
119K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
ddwn
|
381 |
119K |
2 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
381
|
119K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
11 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
457
|
142K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
15 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
212
|
82K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
7 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
212
|
82K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
11 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
457
|
142K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
52 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
457
|
142K
|
52
|
|
ASX - By Stock
|
MSB |
Re:
NASDAQ hot!!!
|
|
ddwn
|
212 |
82K |
8 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
212
|
82K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
23 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
457
|
142K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
8 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
457
|
142K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
ddwn
|
457 |
142K |
25 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
457
|
142K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
ddwn
|
226 |
73K |
4 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
73K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
ddwn
|
226 |
73K |
7 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
73K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Partnership deals......
|
|
ddwn
|
102 |
19K |
15 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
102
|
19K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Partnership deals......
|
|
ddwn
|
102 |
19K |
25 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
102
|
19K
|
25
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
ddwn
|
18K |
10M |
7 |
21/03/24 |
21/03/24 |
ASX - By Stock
|
18K
|
10M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
ddwn
|
510 |
148K |
7 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
510
|
148K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
ddwn
|
510 |
148K |
8 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
510
|
148K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
ddwn
|
510 |
148K |
4 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
510
|
148K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
ddwn
|
510 |
148K |
5 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
510
|
148K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
ddwn
|
18K |
10M |
3 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
18K
|
10M
|
3
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
ddwn
|
18K |
10M |
2 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
18K
|
10M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
ddwn
|
510 |
148K |
16 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
510
|
148K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
ddwn
|
510 |
148K |
18 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
510
|
148K
|
18
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
ddwn
|
18K |
10M |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
18K
|
10M
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
ddwn
|
18K |
10M |
12 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
18K
|
10M
|
12
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
ddwn
|
18K |
10M |
5 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
18K
|
10M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
ddwn
|
154 |
44K |
36 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
44K
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
ddwn
|
154 |
44K |
11 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
44K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
ddwn
|
154 |
44K |
6 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
44K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
ddwn
|
154 |
44K |
24 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
44K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
ddwn
|
510 |
148K |
10 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
510
|
148K
|
10
|
|